Primary stroke prevention worldwide: translating evidence into action
Stroke is the second leading cause of death and the third leading cause of disability
worldwide and its burden is increasing rapidly in low-income and middle-income countries …
worldwide and its burden is increasing rapidly in low-income and middle-income countries …
Stroke in Africa: profile, progress, prospects and priorities
Stroke is a leading cause of disability, dementia and death worldwide. Approximately 70% of
deaths from stroke and 87% of stroke-related disability occur in low-income and middle …
deaths from stroke and 87% of stroke-related disability occur in low-income and middle …
[HTML][HTML] Editor's Choice–European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral …
R Naylor, B Rantner, S Ancetti, GJ de Borst… - European Journal of …, 2023 - Elsevier
Each section has been revised or rewritten and five new sections added:(i) management of
free floating thrombus (section 4.13),(ii) management of carotid webs (section 4.14),(iii) …
free floating thrombus (section 4.13),(ii) management of carotid webs (section 4.14),(iii) …
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
GBD Collaborators, VL Feigin, BA Stark… - The Lancet …, 2021 - escholarship.org
BackgroundRegularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
[HTML][HTML] Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
GBD 2019 Stroke Collaborators - The Lancet. Neurology, 2021 - ncbi.nlm.nih.gov
Background Regularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
VL Feigin, BA Stark, CO Johnson, GA Roth… - The Lancet …, 2021 - thelancet.com
Background Regularly updated data on stroke and its pathological types, including data on
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are …
A single-cell atlas of the normal and malformed human brain vasculature
Cerebrovascular diseases are a leading cause of death and neurologic disability. Further
understanding of disease mechanisms and therapeutic strategies requires a deeper …
understanding of disease mechanisms and therapeutic strategies requires a deeper …
Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: results from global burden of disease study 2017
Abstract Background Cardiovascular diseases (CVDs) are one of the global leading causes
of concern due to the rising prevalence and consequence of mortality and disability with a …
of concern due to the rising prevalence and consequence of mortality and disability with a …
Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years
Background and purpose: Prediction of stroke impact provides essential information for
healthcare planning and priority setting. We aim to estimate 30-year projections of stroke …
healthcare planning and priority setting. We aim to estimate 30-year projections of stroke …
Drug delivery to the central nervous system
Despite the rising global incidence of central nervous system (CNS) disorders, CNS drug
development remains challenging, with high costs, long pathways to clinical use and high …
development remains challenging, with high costs, long pathways to clinical use and high …